Found: 6
Select item for more details and to access through your institution.
Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 5, p. 2881, doi. 10.1002/ehf2.14736
- By:
- Publication type:
- Article
Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 5, p. 3875, doi. 10.1002/ehf2.13541
- By:
- Publication type:
- Article
Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
- Published in:
- Neurology & Therapy, 2018, v. 7, n. 1, p. 87, doi. 10.1007/s40120-018-0097-9
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta-Analysis.
- Published in:
- Journal of the American Geriatrics Society, 2015, v. 63, n. 5, p. 1002, doi. 10.1111/jgs.13395
- By:
- Publication type:
- Article